Your browser doesn't support javascript.
loading
Combination therapy with protein kinase inhibitor H89 and Tetrandrine elicits enhanced synergistic antitumor efficacy.
Yu, Man; Liu, Ting; Chen, Yicheng; Li, Yafang; Li, Wenhua.
Afiliación
  • Yu M; Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan University, Wuhan, 430072, People's Republic of China.
  • Liu T; Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan University, Wuhan, 430072, People's Republic of China.
  • Chen Y; Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan University, Wuhan, 430072, People's Republic of China.
  • Li Y; Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan University, Wuhan, 430072, People's Republic of China.
  • Li W; Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan University, Wuhan, 430072, People's Republic of China. whli@whu.edu.cn.
J Exp Clin Cancer Res ; 37(1): 114, 2018 Jun 04.
Article en En | MEDLINE | ID: mdl-29866132
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Sulfonamidas / Bencilisoquinolinas / Inhibidores de Proteínas Quinasas / Isoquinolinas / Antineoplásicos Tipo de estudio: Prognostic_studies Idioma: En Revista: J Exp Clin Cancer Res Año: 2018 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Sulfonamidas / Bencilisoquinolinas / Inhibidores de Proteínas Quinasas / Isoquinolinas / Antineoplásicos Tipo de estudio: Prognostic_studies Idioma: En Revista: J Exp Clin Cancer Res Año: 2018 Tipo del documento: Article